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Abstract
Introduction: The objective of this study was to investigate the relationship
between microvascular and macrovascular disturbances in patients with type 2
diabetes, as shown by results of ophthalmological examination and by vascular
and perfusion examinations of the lower limbs.
Material and methods: A total of 85 patients with type 2 diabetes and an
additional cardiovascular risk factor were enrolled in the study. All patients
underwent complex ophthalmological examination, including fundus colour
photography and fluorescein angiography, and were divided into two groups:
group I with signs of diabetic non-proliferative retinopathy (NPDR), and group
II with signs of diabetic proliferative retinopathy (P/PDR). After collection of the
general medical history and analysis of medical data, patients underwent
vascular and muscle perfusion examination of the lower limbs.
Results: In the P/PDR group, disturbances of lower-limb perfusion were more
frequent than in the NPDR group. Analysis of the blood flow and results of lower-
limb muscle perfusion for the two groups showed a significant relationship with
the severity of microvascular complications observed in examination of the
fundus.
Conclusions: Ophthalmological assessment of the progression of diabetic
retinopathy in patients with type 2 diabetes is a reliable indicator of the changes
in peripheral vessel systems and perfusion defects in the lower limbs.
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Introduction
Diabetes and its complications are important therapeutic problems.
Early recognition and treatment of the vascular complications of type 2
diabetes, such as diabetic angiopathy, diabetic retinopathy, and muscle
perfusion disturbances, are critical. The non-invasive and sensitive tests
for detecting these complications include indirect ophthalmoscopy and
fluorescein angiography of the retina, together with muscle perfusion
scintigraphy of the lower limbs [1]. 
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progression of changes in the eyes and intensity of
muscle perfusion in the legs is very important for
a clinical diagnosis. Identification of such a relation
would allow for a quick, non-invasive evaluation of
the risk of both microangiopathic and macro  -
angiopathic vascular complications in patients with
type 2 diabetes [1, 2].
Therefore the aim of the study was to (1) define
the correlation between the intensity of diabetic
retinopathy and muscle perfusion disturbances in
the legs of patients with type 2 diabetes; (2) assess
the extent to which the progression of diabetic
retinopathy can be a determinant of a perfusion
impairment in patients with type 2 diabetes and
thereby recommend appropriate diagnostic tests
for lower-limb perfusion disturbances. 
Material and methods
Eighty-five patients with type 2 diabetes aged
50 to 75 (41 women and 44 men) were included in
the analysis. 
Patients with glaucoma, senile macular
degeneration, high myopia, and retinal diseases and
those who had had interventions that precluded
use of the typical classification of diabetic
retinopathy were excluded from the study, as well
as patients who had had myocardial infarction and
stroke and surgical procedures involving the lower-
limb muscles. The duration of type 2 diabetes was
10 to 26 years (16.88 ±4.54). The patients were
selected on the basis of progression of retinopathy
as defined by an ophthalmologist with more than
5 years' experience diagnosing retinopathy. On the
basis of the progression of retinopathy, the patients
were included in one of two groups. In each group,
there were subgroups of patients treated with
insulin and oral drugs:
Group 1 – NPDR (non-proliferative diabetic
retinopathy) consisted of 43 patients (27 men and
16 women, aged 50-67) with changes typical of
non-proliferative diabetic retinopathy. The inclusion
criterion was the presence of at least one
microaneurysm confirmed by ophthalmological
examination, eye fundus photographs, or eye
fundus fluorescein angiography. The group was
divided into 2 subgroups depending on the type of
diabetes treatment; the subgroup taking drugs
orally consisted of 25 patients aged 57 ±4.51 years,
and the subgroup receiving insulin consisted of 18
patients aged 59 ±5.71 years.
Group 2 – P/PDR (pre-proliferative and
proliferative diabetic retinopathy) consisted of 42
patients (23 men and 19 women, aged 50-75) who
had any eye fundus neovascularization cha  -
racteristic for proliferative diabetic retinopathy in
any location (neovascularization of the optic disc
[NVD], neovascularization elsewhere [NVE]). The
subgroup taking drugs orally consisted of 18
patients aged 63 ±7.61 years, and the subgroup
receiving insulin included 24 patients aged 65 ±7.61
years.
All patients underwent subjective and objective
physician assessment, as well as complex
ophthalmological assessment. These included
assessments of:
•  general history, including age, sex, diabetes
duration, past medical treatment;
•  history concerning risk factors leading to
circulation disturbances of lower limbs;
• history concerning eye diseases;
• ophthalmological examination, including best
corrected visual acuity, intraocular pressure, full
examination of the anterior segment of the eye,
fundus examination by indirect ophthalmoscopy,
digital colour fundus photography and fluorescein
angiography.
The scale elaborated by the Global Diabetic
Retinopathy Group was used for assessment of
diabetic retinopathy progression [1]. 
Colour photography and fluorescein angiography
were performed with a TRC 50EX Topcon fundus
camera, Topcon, equipped with the lens system TL
211 and digital camera with resolution of 12
megapixels (Nikon D2).
Seven standard non-stereoscopic fundus pictures
in the 30° range according to the ETDRS standard
were obtained. The presence of the following was
assessed for entry to the study groups:
microaneurysms, haemorrhages, hard exudates,
venous beading, change in the width of venous
vessels, intra-retinal microvascular abnormalities
(IRMA), cotton wool spots, retinal oedema,
neovascularization of optic disc (NVD) and retinal
neovascularization elsewhere (NVE), according to
standard ETDRS pictures.
In all patients the radioisotopic assessment of
lower-limb muscle perfusion at rest was performed.
Scintigraphic examination of lower-limb perfusion
was performed with a gamma-camera after the
intravenous administration of technetium 99m
methoxy-isobutylisonitrate (MIBI Tc99m), activity
11.1 MBq/kg b.m. (body mass); 5 min after the
injection, a scintigram of the entire body was
obtained, together with static scintigrams of lower-
limb muscles. The pictures were mathematically
analysed with the Assessment Limb Lower
Perfusion (ALLP) program, which defined the muscle
perfusion indexes of stress and rest: WPLP
indicated the perfusion index of the left tibial
muscles; WPPP – perfusion index of the right tibial
muscles; WPLU – perfusion index of the left femoral
muscles; and WPPU – perfusion index of the right
femoral muscles. The perfusion index values
allowed for definition of the calf perfusion index
(WPP) and thigh perfusion index (WPU) [2-4].
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allowed us to define for diagnostic purposes
a range of normal values for WPP and WPU at rest
in young patients and in patients more than 
50 years of age (Table I). The results of these values
were compared to those obtained in previous
studies [5].
We also examined the pulse, calculated ankle-
brachial indexes (ABI), measured the blood flow
maximal speed (Vmax.), and indicated the pulse
index (PI) and resistance index (RI) in the selected
arteries in the typical locations. 
Statistical analysis
All the calculations were performed with the
STATISTICA PL 8 software (StatSoft, Poland). The
average value and standard deviation were given
for the measurable variables. The hypothesis of
normal distribution was verified with the Shapiro-
Wilk test. The test power for the radioisotopic
indexes was defined, and the correlation between
the ankle-brachial index and lower-limb perfusion
indexes was calculated as well as correlations
between eye fundus fluorescein angiography and
perfusion indexes of the lower-limb muscles. The
sensitivity and specificity of the utilized method
were determined.
Results
Eye fundus fluorescein angiography results
Fundus fluorescein angiography allows for
qualitative assessment of eye fundus lesions,
including in diabetic retinopathy. Repeatable results
were obtained for the particular grades of diabetic
retinopathy advancement in the conducted study. 
Due to the repeatability of the obtained results
it was possible to assign significant numerical
values (DV) to the grades of diabetic retinopathy
advancement.
Assigned numerical values (DV) allowed for
statistical analysis of the relationship between the
advancement of the diabetic retinopathy and lower-
limb muscle perfusion disturbances.
There were distinguished four characteristics
repeating the descriptions of the fundus fluorescein
angiography results in group I (NPDR). These are
presented in Table II.
There were distinguished three characteristics
repeating the descriptions of the fundus fluorescein
angiography results in group II (P/PDR). These are
presented in Table III. 
Mean numerical values (DV) of all the included
patients were statistically analysed. The mean
numerical value (DV) of each patient was calculated
from the mean numerical values (DV) obtained for
the left and right eye of each individual patient.
Normal Muscle  perfusion indexes*
values range
At rest On exercise
WPP WPU WPP WPU
Lower 9.00 7.34 6.90 5.91
Upper 6.16 4.98 4.54 4.63
*Perfusion indexes are nameless numbers. In the applied method an
increase in index value indicates worsening of perfusion
* DD – disc diameter    
Table I. Range of normal values of the indexes in
patients more than 50 years of age
Fundus fluorescein angiography description (DV) numerical value
Presence of any (i.e. even a small number) of the microaneurysms.  1
Lack of any other lesion characteristic for diabetic retinopathy
Presence of the higher number of microaneurysms, small number of intraretinal hemorrhages,  2
any hard exudates, any IRMA’S, any venous changes
Presence of large number of microaneurysms, hard exudates, IRMA’S, venous changes,  3
intraretinal hemorrhages (less than 20), any cotton wool spots
Presence any of lession 4
– intraretinal hemorrhages in 4 retina quadrants
– venous caliber abnormalities such as: venous beading, loops and dilation
– high number of IRMA’S in at least one retina quadrant
Table II. Group I (NPDR) fundus fluorescein angio  graphy results and DV numerical values
Fundus fluorescein angiography description (DV) numerical value
Presence of any NVE of NVD 1
Simultaneous presence of NVD covering < 1/4 DD* area and NVE covering < 1/2 DD* 2
Presence of NVD covering > 1/4 DD* area and/or NVE covering > 1/2 DD* 3
Table III. Group II (P/PDR) fundus fluorescein angiography results and DV numerical values
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The Shapiro-Wilk test confirmed the normal
distribution hypothesis for the perfusion indexes at
rest in all groups.
Group I – NPDR (Figure 1)
In the subgroup of 25 patients treated with oral
medication, 7 (25%) had worsening of calf
perfusion, and 2 (8%) had worsening of thigh
perfusion. The perfusion index values were in the
range 6.67 < WPP < 9.85 and 5.14 < WPU < 7.64. In
the insulin subgroup of 18 patients, worsening calf
perfusion was observed in 12 (67%), and in 11 (61%)
thigh perfusion worsened. The perfusion index
values were in the range 8.87 < WPP < 10.56 and
7.06 < WPU < 8.99.
Group II – P/PDR (Figure 2)
In the subgroup of 18 patients who were treated
with oral medications, 13 (66%) had worsening
perfusion of the calf (WPP) and thigh (WPU). The
perfusion index values were in the range 8.65 
< WPP < 12.92 and 6.77 < WPU < 10.97. In the
insulin subgroup of 24 patients, worsening calf
perfusion was observed in 20 (83%) and worsening
thigh perfusion in 19 (79%). The perfusion index
values were in the range 7.05 < WPP < 13.44 and
6.01 < WPU < 11.16. 
The calf perfusion index (WPP) and thigh
perfusion index (WPU) in the subgroups underwent
the test power assessment.
The perfusion indices of the calf (WPP) and thigh
(WPU) in the subgroups underwent the test power
assessment. With the zero hypothesis, Mi1 = Mi0,
and in relation to the lower-limb perfusion index
values in the group of patients more than 50 years
of age without the lower-limb perfusion distur  -
bances defined on the basis of clinical exami  -
nations, a very high test power was achieved for all
cases presented in Table IV.
The small number of patients does not allow for
the indication of reliable statistical significance of
differences between the perfusion indices in the
subgroups treated orally vs. those treated with insulin.
There was a positive correlation between lower-
limb muscle perfusion and fundus diabetic
retinopathy results. The strength of this correlation
was average in all the NPDR group and high in all
the P/PDR group (Table V). 
Calculated perfusion indexes allowed us to
define sensitivity and specificity of the analysed
interrelation between advancement of diabetic
retinopathy and lower-limb muscles’ perfusion
impairment. The results are presented in Table VI.
Characteristic for group I (NPDR) was relatively
low sensitivity and very high specificity of the
method. Moreover, with increasing advancement
of diabetic retinopathy (group II – P/PDR), high
sensitivity and also high specificity were observed.
Results of vascular examinations 
Figure 3 presents the distribution of the
resistance index (RI), pulse index (PI), and the
maximal speed of blood flow (Vmax.) measured in
the femoral artery and the ABI. Along with an
increased progression of retinopathy, greater
dispersion of the values was observed, and the
indices increased beyond the normal range.
The power of correlation between the ABI and
the calf perfusion index (WPP) and thigh perfusion
11
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6
5
4
WPP-oral WPP-insulin
WPU-oral WPU-insulin
Figure 1. Distribution of results of radioisotopic
examination in group 1 – NPDR 
Average
Average ± rang trust
Min. - max.
Protruding
Extreme
14
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WPP-oral WPP-insulin
WPU-oral WPU-insulin
Figure 2. Distribution of results of radioisotopic
examination in group 2 – P/PDR
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Average
Average ± rang trust
Min. - max.
Protruding
Extremeindex (WPU) is presented in Table VII. It was found
that correlation power increased along with the
progression of retinopathy. In the simple
retinopathy (NPDR) group a lack of correlation was
found in the subgroup treated orally. In the insulin
subgroup of the NPDR group and in both subgroups
of the proliferative and pre-proliferative retinopathy
(P/PDR) group, an average correlation power
between the indices was observed. The observed
correlation was negative, which means that the
dependency between the ankle-brachial and
perfusion indexes was inversely proportional.
A stronger correlation of the ABI and calf perfusion
indexes was observed than between the ABI and
thigh perfusion indexes. This may result from the
fact that the ABI is calculated on the basis of the
pressure measured in the dorsal artery of the calf.
The absolute values of the muscle perfusion
indexes increased, while the value of the ankle-
brachial index decreased, which confirmed
worsening circulation.
Discussion
Diseases of peripheral vessels are a common
complication of type 2 diabetes. In patients with
diabetes, the risk of vascular disease is increased
by advanced age, smoking, hypertension, lipid
metabolism disturbances, diabetes duration, and
the presence of peripheral neuropathy [6-11]. The
real frequency of lower-limb disturbances of muscle
perfusion is difficult to assess because of a lack of,
or a small number of, symptoms in a large group
of patients. Hiatt et al. reported that in a group of
patients with vascular disease, more than 50% did
not claim any symptoms, about 1/3 had intermittent
claudication, and only the remaining ones had more
severe forms of the disease [12]. However, even in
asymptomatic patients, perfusion disturbances of
the lower limbs indicate systemic vascular disease
[10, 12-17]. Microangiopathic and macroangiopathic
disturbances may be prognostic for the course of
muscle vascular diseases in patients with diabetes,
and numerous observations suggest the presence
of a common pathological mechanism of
disturbance. Cosson et al. demonstrated the
presence of diabetic retinopathy in patients with
type 2 diabetes [15]. In our study we analysed the
mutual correlation of microangiopathic and
macroangiopathic disturbances in patients with
type 2 diabetes and the relation of the frequency
of co-existence of sight complications to
disturbances of lower-limb peripheral perfusion.
Applied non-invasive diagnostic methods that allow
for early recognition of lower-limb ischemia clinically
and prognostically benefit patients with type 2
Group I – NPDR Group II – P/PDR
Oral treatment Insulin treatment Oral treatment Insulin treatment
WPP WPU WPP WPU WPP WPU WPP WPU
Population mean (Mi) 8.2440 6.7500 9.4570 7.8270 10.621 8.4480 11.020 8.9040
SD (Sigma) 0.9237 0.6380 0.5340 0.6320 1.4030 1.2030 1.6300 1.5100
number (N) 25.000 25.000 18.000 18.000 24.000 24.000 24.000 24.000
Power 0.9315 0.9933 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000
Table IV. Assessment of the test power of the analyzed indexes 
Perfusion index vs. fluorescein angiography (DV)
Group I – NPDR Group II – P/PDR
Oral treatment Insulin treatment  Oral treatment            Insulin treatment
WPP WPU WPP WPU WPP WPU WPP WPU
Correlation (r Pearson) 0,49 0,52 0,65 0,64 0,74 0,70 0,77 0,74
Table V. Relationship between the results of radioisotopic indices of the lower limb muscle perfusion and fundus
diabetic retinopathy results
Group I – NPDR Group II – P/PDR
Oral treatment Insulin treatment Oral treatment Insulin treatment
Sensitivity [%] 47.2 64.1 75.6 82.9
Specificity [%] 92.0 87.4 78.7 81.2
Table VI. Sensitivity and specificity of the method in the particular studied groups
power; one mean, test t, H0: Mi1 = Mi0; p < 0,05
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advanced and often recognized too late. The current
literature does not clearly answer the question
whether progression of diabetic retinopathy is an
important indicator of increased risk of vascular
disease [16, 18, 19]. Lower-limb ischemia may
develop in 20% to 50% of patients with type 2
diabetes, and ophthalmological examinations seem
useful in the detection of early changes in
peripheral vessels in such patients [19, 20]. Our
study aimed to answer the question whether
ophthalmological examination can determine which
patients with type 2 diabetes should be evaluated
for peripheral perfusion disturbances, even with
a lack of clinical symptoms, and to what extent the
progression of eyeground changes correlates with
the development of changes in peripheral perfusion.
A finding of such dependencies would define which
patients with type 2 diabetes should have a lower-
limb examination. 
Average
Average ± rang trust
Min. - max.
Protruding
Extreme
SIM-oral PRO-oral
SIM-insulin PRO-insulin
SIM-oral PRO-oral
SIM-insulin PRO-insulin
SIM-oral PRO-oral
SIM-insulin PRO-insulin
SIM-oral PRO-insulin
SIM-oral PRO-insulin
1.4
1.2
1.0
0.8
0.6
0.4
1.2
1.0
0.8
0.6
0.4
1.6
1.4
1.2
1.0
0.8
7
6
5
4
3
2
Ankle – brachial indexes  Femoral artery – maximal speed of blood flow [m/s]
Femoral artery – resistance index (RI) Femoral artery – pulse index (PI)
Figure 3. Distribution of basic results of vascular examination in the subgroups 
Perfusion index vs. ankle-brachial index
Group I – NPDR Group II – P/PDR 
Oral treatment              Insulin treatment Oral treatment               Insulin treatment
WPP WPU WPP WPU WPP WPU WPP WPU
Correlation (r Pearson) –0,17 –0,02 –0,53 –0,41 –0,63 –0,60 –0,68 –0,49
Table VII. Value of the correlation between perfusion and ankle-brachial indexes 
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Average
Average ± rang trust
Min. - max.
Protruding
Extreme
Average
Average ± rang trust
Min. - max.
Protruding
Extreme
Average
Average ± rang trust
Min. - max.
Protruding
ExtremeThe indexes of the standard vascular
examinations significantly exceeded normal values.
The ankle-brachial index decreased according to
the advancement of the diabetic retinopathy. The
results of the analysed vascular examinations
suggested impairment of the lower-limb muscle
perfusion but gave no possibilities for precise
quantification of the defects. The application of
perfusion scintigraphy in the study allowed us to
supplement former vascular diagnostic methods
and to evaluate precise disease advancement.
Relatively low sensitivity (47.2%) and very high
specificity (92%) of the research method in group I
(NPDR) – with oral treatment – showed that not all
the patients in this group had lower-limb muscle
perfusion disturbances although all the patients
had diabetic retinopathy.
In group II (P/PDR) sensitivity and specificity of
the method were high and increased along with the
advancement of the diabetic retinopathy, which can
be of prognostic value and an indication for lower-
limb perfusion assessment.  
The patients in our study in whom there were
characteristic changes, especially those with
retinopathy treated with insulin, should undergo
ophthalmological assessment for muscle perfusion
disturbances. Our study appears to logically explain
such a strategy, which can be useful in the
detection of muscle perfusion disturbances in the
course of diabetes.
Conclusions are as follows:
1. Deterioration of lower-limb muscle perfusion
follows advancement of diabetic retinopathy.
2. There are dubious indications for lower-limb
muscle perfusion assessment in group I (NPDR)
according to the low sensitivity (50%) and high
specificity of the utilized methods.
3. There are clear indications and high prognostic
value of the eye fundus examination according
to the lower-limb muscle perfusion disturbances
in group II (P/PDR).
4. Diabetic retinopathy advancement degree is
a significant indication for lower-limb muscle
perfusion assessment despite the lack of
subjective complaints characteristic for lower-
limb muscle ischaemia.
5. There are reasonable arguments to implement
our suggested strategy to uncover lower-limb
perfusion disturbances before the appearance of
significant clinical symptoms characteristic for
micro- and macroangiopathy. 
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